logo
Independent Director of First Busey Picks Up 9.9% More Stock

Independent Director of First Busey Picks Up 9.9% More Stock

Yahoo07-02-2025

Potential First Busey Corporation (NASDAQ:BUSE) shareholders may wish to note that the Independent Director, Stephen King, recently bought US$403k worth of stock, paying US$24.53 for each share. Although the purchase only increased their holding by 9.9%, it is still a solid purchase in our view.
View our latest analysis for First Busey
In fact, the recent purchase by Stephen King was the biggest purchase of First Busey shares made by an insider individual in the last twelve months, according to our records. That means that an insider was happy to buy shares at around the current price of US$25.35. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. The good news for First Busey share holders is that insiders were buying at near the current price.
In the last twelve months First Busey insiders were buying shares, but not selling. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
First Busey is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that First Busey insiders own 6.4% of the company, worth about US$90m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.
It is good to see recent purchasing. And an analysis of the transactions over the last year also gives us confidence. When combined with notable insider ownership, these factors suggest First Busey insiders are well aligned, and that they may think the share price is too low. Of course, the future is what matters most. So if you are interested in First Busey, you should check out this free report on analyst forecasts for the company.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Sasol (JSE:SOL) Welcomes New Board Directors Amid Leadership Reshuffle
Sasol (JSE:SOL) Welcomes New Board Directors Amid Leadership Reshuffle

Yahoo

time15 minutes ago

  • Yahoo

Sasol (JSE:SOL) Welcomes New Board Directors Amid Leadership Reshuffle

Sasol recently saw a 38% rise in its share price last month, coinciding with several key developments. The appointment of Ms. Xikongomelo Maluleke as an independent non-executive director and a revised dividend policy, emphasizing sustainable debt management, may have bolstered investor sentiment. Additionally, Sasol's partnership with Henkel on environmentally friendly adhesives aligns with market trends favoring sustainability, potentially appealing to eco-conscious investors. While these company-specific changes added weight, broader market trends, such as optimism over U.S.-China trade talks, also likely contributed to the positive movement in Sasol's shares. You should learn about the 2 risks we've spotted with Sasol. The end of cancer? These 23 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. The recent appointments and policy revisions at Sasol, alongside its partnership with Henkel, could reinforce the company's focus on cost optimization and environmentally aligned growth strategies, potentially impacting future revenue and earnings positively. These moves, emphasizing renewable energy integration and sustainable debt management, might enhance Sasol's operational efficiency and profit margins over time, supporting the narrative of a strengthened operational framework. Over the past year, Sasol's total shareholder return, including dividends, was a 25.81% decline. Meanwhile, its 12-month price performance shows underperformance compared to both the South African Chemicals industry, which returned a 10.6% decline, and the broader ZA market, which rose 28%. This longer-term perspective underscores the challenges Sasol has faced in navigating market conditions and competitive pressures. While the company's updated initiatives could improve revenue and earnings forecasts, analysts see Sasol's revenue reaching ZAR 269.6 billion, with expectations for substantial earnings growth by June 2028. The share price, currently at ZAR 83.81, remains below the consensus price target of ZAR 118.78, suggesting potential for upward movement if forecasts are met. Investors should consider how these initiatives might align with their expectations and possible industry challenges. Gain insights into Sasol's future direction by reviewing our growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include JSE:SOL. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

Fortive (NYSE:FTV) Reaffirms Q2 2025 Earnings Guidance of US$0.44-US$0.49 EPS
Fortive (NYSE:FTV) Reaffirms Q2 2025 Earnings Guidance of US$0.44-US$0.49 EPS

Yahoo

time18 minutes ago

  • Yahoo

Fortive (NYSE:FTV) Reaffirms Q2 2025 Earnings Guidance of US$0.44-US$0.49 EPS

Fortive recently reaffirmed its earnings guidance for the second quarter of 2025, expecting diluted net earnings per share between $0.44 and $0.49. This stable outlook may have provided some support to their shares, which rose by 4% over the past week. This movement occurred amid broader market gains, aligning with the overall uptrend. As the market climbed 1.5% with anticipation around U.S.-China trade talks and corporate earnings, Fortive's performance seems to have echoed this positive sentiment. Meanwhile, external factors like rising indices may have outweighed any isolated company-specific developments. We've identified 1 warning sign with Fortive and understanding the impact should be part of your investment process. Find companies with promising cash flow potential yet trading below their fair value. The recent reaffirmation of Fortive's earnings guidance appears to have provided some confidence to investors, contributing to the 4% rise in its share price over the past week. This news aligns with broader market movements, as the market increased by 1.5% amid positive sentiments surrounding U.S.-China trade discussions and corporate earnings. Over the past five years, Fortive has achieved a total shareholder return of 38.83%, including both share price appreciation and dividends. This return provides a longer-term perspective, surpassing some expectations within the machinery industry, which had a 9.9% return over the past year, where Fortive underperformed. This latest guidance update may influence future revenue and earnings forecasts positively by reinforcing confidence in Fortive's stability. Analysts are keenly watching how Fortive's separation into New Fortive and Ralliant could unlock further value through targeted strategies. Given the current share price of US$67.25, just under the analyst consensus price target of US$82.86, the company's short-term rise offers a slight discount opportunity. The emphasis on recurring revenue streams and mitigating tariff impacts remains crucial for sustaining profit margins, as the company aims for revenue stability and improved earnings projections nearing US$1.4 billion by 2028. Fortive's ongoing initiatives are expected to impact revenue and margins as they progress towards these targets. The analysis detailed in our Fortive valuation report hints at an inflated share price compared to its estimated value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:FTV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week
IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week

Yahoo

time18 minutes ago

  • Yahoo

IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week

IQVIA Holdings experienced a 10% rise in share price over the last week, correlating with its recent developments, notably the dosing of the first patient in the RENEW Phase 2 trial and its strategic alliance with Sarah Cannon Research Institute to optimize oncology trials. These initiatives likely provided a positive sentiment boost, aligning well with the broader market momentum, as indices such as the S&P 500 also reached new highs. The market's anticipation over US-China trade talks and overall strong corporate earnings have supported the upward trend, further enhancing IQV's market performance. We've identified 1 warning sign for IQVIA Holdings that you should be aware of. Uncover 18 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. The recent 10% rise in IQVIA Holdings' share price has been influenced by important developments like the dosing in the RENEW Phase 2 trial and a key alliance with Sarah Cannon Research Institute. These initiatives are expected to potentially drive revenue growth, particularly as the strategic alliance optimizes oncology trials. The company's past performance, with total returns of 10.45% over five years, suggests modest growth in investor value. However, compared to the US Life Sciences industry's one-year return of 27% decline, IQVIA's recent rise highlights positive market sentiment. These initiatives, combined with FDA reforms and NVIDIA collaboration, may lower operational costs and have a favorable impact on earnings forecasts. Analysts predict revenue to grow by 5.2% annually over the next three years, which is somewhat cautious compared to the general expectations for the life sciences sector. The recent share price movement to US$146.2 remains below the consensus price target of US$216.31, indicating potential for future appreciation if the projected growth in revenue and earnings materializes. Click here to discover the nuances of IQVIA Holdings with our detailed analytical financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:IQV. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store